G01N 33/5751
Of the skin
Official title: of the skin, e.g. melanoma
G01N33/5751 (Of the skin) appears on 357 US grants and 655 published applications in this corpus.
Search patents in G01N- Granted patents
- 357
- Published applications
- 655
- Assignees
- 314
- Inventors
- 1,188
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 8 | 0 |
| 1997 | 9 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 9 | 0 |
| 2001 | 5 | 0 |
| 2002 | 3 | 10 |
| 2003 | 5 | 14 |
| 2004 | 3 | 8 |
| 2005 | 4 | 7 |
| 2006 | 7 | 18 |
| 2007 | 6 | 20 |
| 2008 | 10 | 18 |
| 2009 | 6 | 20 |
| 2010 | 15 | 21 |
| 2011 | 6 | 29 |
| 2012 | 6 | 36 |
| 2013 | 16 | 22 |
| 2014 | 14 | 28 |
| 2015 | 17 | 43 |
| 2016 | 20 | 61 |
| 2017 | 11 | 36 |
| 2018 | 15 | 37 |
| 2019 | 20 | 28 |
| 2020 | 18 | 43 |
| 2021 | 19 | 38 |
| 2022 | 11 | 30 |
| 2023 | 12 | 22 |
| 2024 | 19 | 25 |
| 2025 | 18 | 23 |
| 2026 | 14 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Molecular profiling of tumors21 Jul 2026US 12,687,554 B2Caris MPI, Inc.
- Tissue-derived extracellular vesicles and their use as diagnostics19 May 2026US 12,631,643 B2Exocure Sweden AB
- Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody5 May 2026US 12,617,850 B2Bristol-Myers Squibb Company
- Diagnostic and prognostic utility of exosomes in immunotherapy28 Apr 2026US 12,613,238 B2Board of Regents, The University of Texas System
- Methods for inhibiting resistance to immune blockade inhibitor therapy24 Sep 2026US 2026/0283997 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Treatment and diagnosis of melanoma17 Sep 2026US 2026/0272867 A1The Rockefeller University
- Collagen Type VI Alpha-6 Assay3 Sep 2026US 2026/0259223 A1Nordic Bioscience A/S
- Molecular profiling of tumors3 Sep 2026US 2026/0259233 A1Caris MPI, Inc.
- Melanoma targeting human antibodies and therapeutic uses thereof27 Aug 2026US 2026/0250415 A1Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - Irst S.R.L.
Most cited
By later US patents
- Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis88US 5,310,653 ABoard of Regents, The University of Texas System · 1994
- Tumor immunotherapy using anti-idiotypic antibodies75US 4,918,164 AOncogen · 1990
- Variants of humanized anti carcinoma monoclonal antibody cc4975US 6,818,749 B1The United States of America as represented by the Department of Health and Human Services · 2004
- Intercellular adhesion molecules, and their binding ligands66US 5,284,931 ADana-Farber Cancer Institute, Inc. · 1994
- Recombinant viruses encoding the human melanoma-associated antigen61US 5,262,177 AOncogen · 1993